Choline Fenofibrate

Choline Fenofibrate (ABT-335), a choline salt of Fenofibric acid (HY-B0760), releases free Fenofibric acid in the gastrointestinal tract. Fenofibric acid is a PPAR activator with antihyperlipidemic effect[1].

Product Specifications

CAS Number

[856676-23-8]

Product Name Alternative

ABT-335

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

COX; PPAR

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

Applications

COVID-19-anti-virus

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Choline-Fenofibrate.html

Purity

99.86

Solubility

DMSO : 20 mg/mL (ultrasonic) |Ethanol : 33.33 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=C(OC(C)(C([O-])=O)C)C=C1)C2=CC=C(Cl)C=C2.C[N+](C)(CCO)C

Molecular Formula

C22H28ClNO5

Molecular Weight

421.91

Precautions

H302, H315, H319, H335

References & Citations

[1]Xudan Wei, et al. Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry. Biomed Chromatogr. 2017 Apr;31 (4) .